Jump to content

Idramantone

From Wikipedia, the free encyclopedia

Idramantone
Clinical data
Other namesKemantane; Kemantan; 5-Hydroxyadamantanone; 4-Oxo-1-adamantanol; 4-Oxoadamantan-1-ol; 1-Hydroxy-4-ketoadamantane
Identifiers
  • 5-hydroxyadamantan-2-one
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
Chemical and physical data
FormulaC10H14O2
Molar mass166.220 g·mol−1
3D model (JSmol)
  • C1C2CC3CC(C2)(CC1C3=O)O
  • InChI=1S/C10H14O2/c11-9-7-1-6-2-8(9)5-10(12,3-6)4-7/h6-8,12H,1-5H2
  • Key:TZBDEVBNMSLVKT-UHFFFAOYSA-N

Idramantone, also known as kemantane or as 5-hydroxyadamantan-2-one, is an experimental immunostimulant of the adamantane group that was never marketed.[1][2] It is described as a lymphocyte and antibody stimulant in mice and as a T-cell suppressor.[1][2] The drug was first described by 1968.[1]

References

[edit]
  1. ^ a b c Buckingham J, Macdonald F (1996). Dictionary of Organic Compounds (Sixth, Supplement 1 ed.). Taylor & Francis. p. 152. ISBN 978-0-412-54110-0. Retrieved 13 September 2024.
  2. ^ a b Morton IK, Hall JM (2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Netherlands. p. 145. ISBN 978-94-011-4439-1. Retrieved 13 September 2024.